胎儿囊性淋巴管畸形:妊娠与新生儿结局的系统综述
该系统综述纳入2000至2022年间65项研究共96例胎儿,评估排除后颈部起源的胎儿囊性淋巴管畸形的妊娠与新生儿结局。平均诊断孕周25.5周,最常见位于前颈部(28%),产前病灶增大、瘤内出血及胎儿水肿分别占70%、9%和3%,活产率94%,幸存者发育结局正常。
要点
- 排除后颈部起源的胎儿囊性淋巴管畸形通常不伴染色体或额外结构异常。
- 产前病灶增大常见(70%),但瘤内出血(9%)和胎儿水肿(3%)少见。
- 活产率94%,幸存者随访中发育结局正常。
核心结论
- 排除后颈部起源的胎儿囊性淋巴管畸形通常不伴染色体或额外结构异常,产前多增大但仅少数出现并发症,所有幸存者发育结局良好。
研究设计与样本
- 系统综述,遵循PRISMA指南,纳入2000至2022年发表的病例系列和病例报告共65项研究、96例胎儿,所有病例均用二维超声诊断淋巴管畸形。
关键影像表现/征象
- 最常见部位为前颈部,占28%。
- 产前淋巴管畸形增大占70%(41/59),瘤内出血占9%(5/59),胎儿水肿占3%(2/59)。
- 染色体异常占4%(2/52),结构异常占2%(2/96)。
诊断标准与关键数值
- 平均诊断孕周为25.5周。
- 活产率为94%(79/84),12/96例终止妊娠,5/84例宫内死亡。
- 平均分娩孕周为37.7周,阴道分娩占19%(15/79),其中1例发生肩难产。
临床应用与阅片要点
- 产前咨询时可参考:排除后颈部起源的胎儿囊性淋巴管畸形通常不伴染色体或额外结构异常。
- 产前超声随访中病灶增大常见(70%),但瘤内出血和胎儿水肿仅少数发生。
- 产后治疗以手术切除(38%,30/79)、硬化治疗(21.5%,17/79)或两者联合(11.4%,9/79)常见。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Evaluate pregnancy and neonatal outcomes with fetal cystic lymphatic malformations (LMs), excluding those arising from the posterior neck, to facilitate patient counseling.
METHOD: A systematic review was performed in accordance with PRISMA guidance. Case series and case reports published between 2000 and 2022 were included.
RESULTS: Sixty-five studies (96 fetuses) met the inclusion criteria. The average gestational age at diagnosis was 25.5 weeks with the commonest location being the anterior neck (28%). All patients were diagnosed with LM using two-dimensional (2D) ultrasound. Prenatal progression in LM size, presence of intralesional bleeding, or fetal hydrops occurred in 70% (41/59), 9% (5/59), and 3% (2/59), respectively. Chromosomal and structural abnormalities were reported in 4% (2/52) and 2% (2/96), respectively. Overall livebirth rate was 94% (79/84); 12/96 resulted in termination and 5/84 in in utero demise. The average gestational age of delivery was 37.7 weeks. Exactly 19% (15/79) had a vaginal birth, of which shoulder dystocia occurred in one infant. Ex utero intrapartum treatment (EXIT) procedure was performed in 13% (10/79). Postnatal treatment commonly involved surgical excision 38% (30/79), sclerotherapy in 21.5% (17/79), or combination of both in 11.4% (9/79). Of those with reported follow-up, 4 died within 1 year, 1 developed heart failure at 2 years of life, and the remaining 44 had normal developmental outcomes.
CONCLUSION: Fetal cystic LMs, excluding those in the posterior neck, are not commonly associated with chromosomal, or additional structural abnormalities. They usually increase in size before delivery with only a minority developing complications. The good developmental outcome was reported in all survivors.
引用
- Nzelu D, Panayotidis I, Smith GD, et al. Fetal Cystic Lymphatic Malformations: Systematic Review on Pregnancy and Neonatal Outcomes. J Ultrasound Med. 2024. PMID: 39248487. doi:10.1002/jum.16566
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。